Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07874542
Recruiting
Plasma DNA Methylation for Preoperative Classification of Renal Masses
Not applicable · China · 1 site
Registry update: 15 Oct 2026
NCT07390539
Recruiting
B7-H3.CD28Z.CART in CNS Neoplasms
Phase 1 · United States · 2 sites
Registry update: 3 Sept 2026
NCT07801287
Recruiting
Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC
Phase 2 · China · 1 site
Registry update: 3 Sept 2026
NCT07840027
Recruiting
Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease
Phase 1 · Austria, Germany · 2 sites
Registry update: 24 Sept 2026
NCT07766538
Recruiting
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait
Not applicable · Kuwait · 1 site
Registry update: 3 Nov 2026
NCT07678593
Recruiting
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
Phase 1/2 · Australia, China · 17 sites
Registry update: 5 Oct 2026
NCT07796516
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Phase 2 · China · 47 sites
Registry update: 1 Sept 2026
NCT07211217
Recruiting
Time Restricted Eating (TRE) in Bipolar Disorder
Not applicable · United States · 1 site
Registry update: 7 Oct 2026
NCT07798323
Recruiting
Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
Not applicable · United States · 1 site
Registry update: 3 Sept 2026
NCT07804186
Recruiting
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
Phase 3 · Canada, United States · 13 sites
Registry update: 15 Sept 2026
NCT07808086
Recruiting
Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer
Not applicable · Italy · 1 site
Registry update: 23 Sept 2026
NCT07918222
Recruiting
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
Phase 3 · China · 1 site
Registry update: 5 Nov 2026
NCT07665515
Recruiting
Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1 · United Kingdom · 10 sites
Registry update: 16 Oct 2026
NCT07799948
Recruiting
Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07844590
Recruiting
Developing New Ways to Detect Respiratory Impairment Early in ALS
Not applicable · United States · 1 site
Registry update: 28 Sept 2026
NCT07849231
Recruiting
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
Phase 1 · Australia, United States · 36 sites
Registry update: 27 Oct 2026
NCT07594483
Recruiting
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Not applicable · United States · 4 sites
Registry update: 2 Nov 2026
NCT07446257
Recruiting
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
Early phase 1 · United States · 1 site
Registry update: 3 Sept 2026
NCT07804615
Recruiting
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Phase 2 · Canada, United States · 30 sites
Registry update: 27 Oct 2026
NCT07371806
Recruiting
EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE
Not applicable · 1 site
Registry update: 11 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.